(CRD-B) Crawford - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2246331076

CRD-B: Claims Management, Claims Adjusting, Risk Management, Repair Management

Crawford & Company (NYSE:CRD-B) is a global leader in claims management and outsourcing solutions, serving insurance carriers, brokers, and corporations across the United States, United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The company operates through four primary segments: North America Loss Adjusting, International Operations, Broadspire, and Platform Solutions.

The North America Loss Adjusting segment specializes in claims management for property, public liability, automobile liability, and marine insurances, catering to insurance carriers and self-insured entities. The International Operations segment provides similar services globally, with a focus on field investigations and the evaluation of property and casualty claims. The Broadspire segment offers comprehensive claims management services, including workers compensation, liability, property, accident, and health claims, alongside disability and leave management, legal services, and risk management analytics. Additionally, Broadspire delivers medical management, desktop claim adjusting, and loss mitigation services such as medical bill review and vocational rehabilitation.

The Platform Solutions segment provides managed repair and outsourced contractor management services, focusing on natural disasters like hurricanes, floods, and earthquakes, as well as man-made disasters such as oil spills and explosions. This segment also offers outsourced subrogation claims management and recovery services. Founded in 1941, Crawford & Company is headquartered in Atlanta, Georgia, and has established itself as a key player in the insurance services industry, leveraging its expertise to streamline claims processes and enhance operational efficiency for clients worldwide.

Based on and , Crawford & Company is expected to maintain its current trajectory with moderate growth in the next three months. The stocks average volume of 4,928 shares and last price of $11.89 suggest stable trading activity, with the SMA 20 at $11.74 and SMA 50 at $11.43 indicating a slight upward trend. The SMA 200 at $10.27 reflects long-term bullish momentum, while the ATR of 0.51 signals moderate volatility.

From a perspective, Crawfords market cap of $588.96M USD and P/E ratio of 29.60 indicate a premium valuation, though the forward P/E of 11.49 suggests potential undervaluation in the future. The P/B ratio of 3.61 and P/S ratio of 0.47 highlight strong equity returns relative to book value and revenue. With an RoE of 12.46%, the company demonstrates efficient profitability. These metrics collectively point to a stable outlook with potential for incremental gains, supported by its diversified service offerings and global reach.

Additional Sources for CRD-B Stock

CRD-B Stock Overview

Market Cap in USD 550m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Life & Health Insurance
IPO / Inception 1990-01-12

CRD-B Stock Ratings

Growth 5y 67.4%
Fundamental 20.1%
Dividend 67.6%
Rel. Strength 11.3
Analysts 5/5
Fair Price Momentum 12.35 USD
Fair Price DCF 12.04 USD

CRD-B Dividends

Dividend Yield 12m 2.53%
Yield on Cost 5y 5.68%
Annual Growth 5y 10.49%
Payout Consistency 82.0%

CRD-B Growth Ratios

Growth Correlation 3m -11.1%
Growth Correlation 12m 79.6%
Growth Correlation 5y 63.3%
CAGR 5y 18.28%
CAGR/Max DD 5y 0.37
Sharpe Ratio 12m 1.36
Alpha 27.27
Beta 0.667
Volatility 43.44%
Current Volume 2.3k
Average Volume 20d 5.2k
What is the price of CRD-B stocks?
As of April 01, 2025, the stock is trading at USD 11.42 with a total of 2,259 shares traded.
Over the past week, the price has changed by +2.33%, over one month by -6.55%, over three months by -1.21% and over the past year by +34.34%.
Is Crawford a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Crawford is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.07 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRD-B as of April 2025 is 12.35. This means that CRD-B is currently overvalued and has a potential downside of 8.14%.
Is CRD-B a buy, sell or hold?
Crawford has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy CRD-B.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CRD-B stock price target?
According to ValueRays Forecast Model, CRD-B Crawford will be worth about 13.4 in April 2026. The stock is currently trading at 11.42. This means that the stock has a potential upside of +17.43%.
Issuer Forecast Upside
Wallstreet Target Price 14 22.6%
Analysts Target Price 13 13.8%
ValueRay Target Price 13.4 17.4%